The CSIR team at U-M Health has the most experience with ablative therapies and has been performing image-guided tumor ablation since 1999. Our team works closely with a multidisciplinary team of healthcare professionals including hepatologists, medical and surgical oncologists, transplant surgeons, urologists, radiation oncologists and interventional radiologists to provide personalized care. We provide state-of-the-art imaging and minimally-invasive cancer treatments using all of the latest ablation technologies including: microwave, radiofrequency, cryoablation, ethanol and ultrasound (histotripsy). 

Combined with our expertise of advanced diagnostic imaging (multi-phase CT, MRI, PET, contrast-enhanced US), our ablation team delivers optimal treatment outcomes for our patients. Our tumor ablation program has successfully treated thousands of patients with primary and metastatic liver cancer, renal cancer, adrenal cancer, prostate cancer, among other sites of disease (lymph nodes, thyroid, etc).  

Our CSIR faculty lead ground-breaking research programs in cancer imaging and intervention. We are inventing the future of image-guided tumor ablation including the development and clinical validation of histotripsy and novel image-guidance techniques (MRI-US) that will improve tumor targeting and confirm treatment success in real time.

Services we offer include:

• Radiofrequency ablation (RFA)
• Microwave ablation (MWA)
• Cryoablation
• Ethanol ablation
• Histotripsy

Please call 734-936-4500 to schedule an appointment or learn more.